6 Results for "

Narcolepsy mouse model

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Narcolepsy mouse model" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-136181
CAS No.: 1804978-82-2
Purity:  99.78%
Research Areas:  

Neurological Disease

YNT-185 dihydrochloride is a nonpeptide, selective orexin type-2 receptor (OX2R) agonist, with EC50s of 0.028 and 2.75 μM for OX2R and OX1R, respectively. YNT-185 dihydrochloride ameliorates narcolepsy-cataplexy symptoms in mouse models .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136181A
CAS No.: 1804978-81-1
Purity:  98.36%
Research Areas:  

Neurological Disease

YNT-185 is a nonpeptide, selective orexin type-2 receptor (OX2R) agonist, with EC50s of 0.028 and 2.75 μM for OX2R and OX1R, respectively. YNT-185 ameliorates narcolepsy-cataplexy symptoms in mouse models .
loading...
    loading...
Cat. No.: HY-133898
CAS No.: 2114324-48-8
Purity:  99.56%
Synonyms: TAK-925
Research Areas:  

Others

Danavorexton (TAK-925) is an orexin receptor agonist with brain permeability. Danavorexton induces a physiological pattern of OX2R activation in vitro to wake up sleepy mice and improve sleepiness symptoms .
loading...
    loading...
Cat. No.: HY-172412
CAS No.: 2648347-56-0
Synonyms: ALKS 2680
Research Areas:  

Neurological Disease

Alixorexton (ALKS 2680) is an orally bioavailable, blood-brain barrier-permeable OX2R-selective activator and wake-promoting agent. Alixorexton can be used for the research of narcolepsy and idiopathic hypersomnia .
loading...
    loading...
Cat. No.: HY-172672
Research Areas:  

Neurological Disease

Orexin 2 Receptor Agonist 3 (Compound 57) is an orally active and brain-penetrant orexin receptor type-2 (OX2) agonist (EC50: 2.5 nM). Orexin 2 Receptor Agonist 3 increases wakefulness in the orexin/ataxin-3 NT1 mouse model and healthy beagle dogs. Orexin 2 Receptor Agonist 3 can be used in the study of narcolepsy .
loading...
    loading...
Cat. No.: HY-183324
Research Areas:  

Neurological Disease

AMPA receptor modulator-12 is an orally acrive AMPA receptor positive allosteric modulator. AMPA receptor modulator-12 also exhibits moderate binding affinity for the human dopamine transporter with a Kd of 1.57 μM. AMPA receptor modulator-12 enhances AMPA receptor-mediated ion currents, delays channel deactivation. AMPA receptor modulator-12 prolongs sleep latency, reduces sleep duration, extends forced swimming time, improves rotarod endurance, and alleviates acute sleep deprivation-related behavioral deficits. AMPA receptor modulator-12 does not increase spontaneous locomotion. AMPA receptor modulator-12 can be used for the research of narcolepsy and fatigue-related conditions .
loading...
    loading...